3-Cyclohexen-1-one,2,6-dihydroxy-3-(hydroxymethyl)-5-[(4-nitrophenyl)amino]-, [2R-(2a,5a,6a)]- (9CI) (92587-08-1)

Identification
Name:	3-Cyclohexen-1-one,2,6-dihydroxy-3-(hydroxymethyl)-5-[(4-nitrophenyl)amino]-, [2R-(2a,5a,6a)]- (9CI)
Synonyms:	N-(4-nitrophenyl)valienamine
CAS:	92587-08-1
Molecular Formula:	C13H14 N2 O6
Molecular Weight:	0
InChI:	InChI=1/C13H14N2O6/c16-6-7-5-10(12(18)13(19)11(7)17)14-8-1-3-9(4-2-8)15(20)21/h1-5,10-12,14,16-18H,6H2/t10-,11+,12-/m0/s1
Molecular Structure:
Properties
Flash Point:	340.3°C
Boiling Point:	639.1°Cat760mmHg
Density:	1.603g/cm³
Refractive index:	1.721
Flash Point:	340.3°C
Safety Data

Other Product

5-Thia-1-azabicyclo[4.2.0]octane-2-carboxylicacid, 3-methylene-8-oxo-7-[(phenylacetyl)amino]-, (4-nitrophenyl)methyl ester,5-oxide, [2R-(2a,5b,6a,7b)]- (9CI)
Spiro[benzofuran-2(3H),2'-[2H]pyran]-6-carboxylicacid, decahydro-3,4'-dihydroxy-3-(hydroxymethyl)-5'-methyl-, [2S-[2a(4'R*,5'S*),3b,3aa,6a,7aa]]- (9CI)
2H-Pyran-2-ol,tetrahydro-3,5-dimethyl-6-(1-methylethyl)-, [2R-(2a,3b,5a,6a)]- (9CI)
3-Morpholinecarboxaldehyde,6-methyl-5-oxo-2-(1,2,3-trihydroxypropyl)-, [2R-[2a(1R*,2R*),3b,6a]]- (9CI)
6-Dodecanone,12-[5-hydroxy-6-(hydroxymethyl)-2-piperidinyl]-, [2R-(2a,5a,6b)]- (9CI)
5-Thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylicacid, 7-amino-8-oxo-, [2R-(2a,6a,7b)]- (9CI)
Androstan-3-one,2-chloro-17-hydroxy-, O-(4-nitrophenyl)oxime, (2a,5a,17b)- (9CI)
2H-Pyran-3-propanoicacid, tetrahydro-4,6-dihydroxy-2-(3-hydroxy-1-octenyl)-, [2R-[2a(1E,3S*),3b,4b,6a]]- (9CI)
Cyclopenta[b]pyran-2-butanoicacid, octahydro-6-hydroxy-5-(3-hydroxy-4-phenoxy-1-butenyl)-, [2R-[2a,4ab,5b(1E,3R*),6a,7ab]]- (9CI)
2-Dodecanone,12-(5-hydroxy-1,6-dimethyl-2-piperidinyl)-, hydrochloride, [2R-(2a,5a,6a)]- (9CI)
2,4(1H,3H)-Pyrimidinedione,1-[4-amino-9-hydroxy-6-(hydroxymethyl)-2,2-dioxido-1,7-dioxa-2-thiaspiro[4.4]non-3-en-8-yl]-5-methyl-,[5R-(5a,6a,8a,9b)]- (9CI)
Androstan-3-one,17-hydroxy-2-(hydroxymethyl)-, (2a,5a,17b)- (9CI)
D-chiro-Inositol,1,5,6-trideoxy-3-O-b-D-glucopyranosyl-5-(hydroxymethyl)-1-[[4,5,6-trihydroxy-3-(hydroxymethyl)-2-cyclohexen-1-yl]amino]-,[1S-(1a,4a,5b,6a)]- (9CI)
Ergostan-1-one,2-(acetyloxy)-6,7-epoxy-22,24,25-[(1S)-ethylidynetris(oxy)]-5-hydroxy-, (2a,5a,6a,7a,22R)- (9CI)
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid,3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isothiazolyl)carbonyl]amino]-7-oxo-,monosodium salt, [2S-(2a,5a,6b)]- (9CI)
2H,3H-Cyclopenta[d']naphtho[1,8-bc:2,3-b']difuran-6-aceticacid,8-(2,5-dihydro-2-hydroxy-5-oxo-3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-3-oxo-,methyl ester (9CI)
2H,3H-Cyclopenta[d']naphtho[1,8-bc:2,3-b']difuran-6-aceticacid,8-(2,5-dihydro-5-hydroxy-2-oxo-3-furanyl)-2a,5a,6,6a,8,9,9a,10a,10b,10c-decahydro-2a,5a,6a,7-tetramethyl-3-oxo-,methyl ester (9CI)
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-, 4-oxide, [2S-(2a,4b,5a,6a)]- (9CI)
1-Azabicyclo[3.2.0]hept-3-ene-2-carboxylicacid, 3-[(2-aminoethyl)thio]-6-(1-hydroxyethyl)-7-oxo-, [2S-[2a,5a,6a(S*)]]- (9CI)
2,4(1H,3H)-Pyrimidinedione,5-methyl-1-[tetrahydro-5-(1-hydroxy-3-oxobutyl)-2-furanyl]-, [2R-[2a,5a(R*)]]- (9CI)